These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

131 related items for PubMed ID: 289863

  • 1. Outpatient experience with saralasin.
    Streeten DH, Anderson GH.
    Kidney Int Suppl; 1979 Mar; (9):S44-52. PubMed ID: 289863
    [No Abstract] [Full Text] [Related]

  • 2. Saralasin in human hypertension: the early experience.
    Brunner HR, Laragh JH.
    Kidney Int Suppl; 1979 Mar; (9):S36-43. PubMed ID: 289862
    [No Abstract] [Full Text] [Related]

  • 3. Use of saralasin in end-stage renal disease.
    Fadem SZ, Lifschitz MD.
    Kidney Int Suppl; 1979 Mar; (9):S93-100. PubMed ID: 289869
    [No Abstract] [Full Text] [Related]

  • 4. [Clinical usefulness of saralasin in human hypertension (author's transl)].
    Fouchard M, Bichara M, Grüfeld JP, Barbanel C, Meyer P, Funck-Brentano JL.
    Nouv Presse Med; 1978 Feb 18; 7(7):539-43. PubMed ID: 643579
    [Abstract] [Full Text] [Related]

  • 5. Saralasin infusion in renovascular and essential hypertension.
    Thien T, Hoefnagels WH.
    Neth J Med; 1980 Feb 18; 23(2):68-73. PubMed ID: 6990282
    [No Abstract] [Full Text] [Related]

  • 6. [Effect of saralasin on normal blood pressure and on reno-vascular hypertension (author's transl)].
    Beckerhoff R, Vetter W, Furrer J, Nussberger J, Schmied U, Siegenthaler W.
    Dtsch Med Wochenschr; 1976 Mar 12; 101(11):398-401. PubMed ID: 1253700
    [Abstract] [Full Text] [Related]

  • 7. [Saralasin for renovascular or essential hypertension (author's transl)].
    Arlart I, Rosenthal J.
    Dtsch Med Wochenschr; 1978 Nov 10; 103(45):1790-6. PubMed ID: 710289
    [No Abstract] [Full Text] [Related]

  • 8. [Saralasin and prediction of the surgical result in renovascular arterial hypertension].
    Mimran A, Deschodt G, Fourcade J, Barjon P.
    Arch Mal Coeur Vaiss; 1979 Nov 10; 72 Spec no():16-21. PubMed ID: 119507
    [Abstract] [Full Text] [Related]

  • 9. Angiotensin as a renal, adrenal, and cardiovascular hormone: responses to saralasin in normal man and in essential and secondary hypertension.
    Hollenberg NK, Williams GH.
    Kidney Int Suppl; 1979 Mar 10; (9):S29-35. PubMed ID: 384070
    [No Abstract] [Full Text] [Related]

  • 10. [Pharmacologic functional examination in arterial hypertension].
    Stumpe KO, Kolloch R, Overlack A.
    Internist (Berl); 1977 Nov 10; 18(11):594-600. PubMed ID: 23361
    [No Abstract] [Full Text] [Related]

  • 11. False-negative saralasin responses in renovascular hypertension.
    Stokes GS, MacCarthy EP, Frost GW, Sheil AG.
    Br J Urol; 1979 Apr 10; 51(2):92-9. PubMed ID: 465980
    [Abstract] [Full Text] [Related]

  • 12. [The Saralasin test in the diagnosis of renovascular hypertension. Personal experience].
    Giuliani L, Martorana G, Giberti C.
    Minerva Nefrol; 1979 Apr 10; 26(4):623-8. PubMed ID: 396491
    [No Abstract] [Full Text] [Related]

  • 13. Effect of saralasin on plasma aldosterone in hypertensive man.
    Brown RD, Tucker R, Tue K, Wisgerhof M, Salassa R.
    J Lab Clin Med; 1978 Mar 10; 91(3):473-9. PubMed ID: 627750
    [No Abstract] [Full Text] [Related]

  • 14. Angiotensin blockade in coarctation of the aorta.
    Ribeiro AB, Krakoff LR.
    N Engl J Med; 1976 Jul 15; 295(3):148-50. PubMed ID: 1272332
    [No Abstract] [Full Text] [Related]

  • 15. Hemodynamic correlates of saralasin: responsiveness in hypertension.
    Kem DC, Frohlich ED, de Carvalho JG, Dunn FG, Chrysant SG, Danisa K, Wambach G.
    Kidney Int Suppl; 1979 Mar 15; (9):S68-74. PubMed ID: 289866
    [No Abstract] [Full Text] [Related]

  • 16. [The saralasin test. Use in diagnosis of nephrovascular hypertension].
    Pigliucci GM, Falappa P, Martino F.
    Minerva Cardioangiol; 1979 Sep 15; 27(9):551-8. PubMed ID: 398451
    [No Abstract] [Full Text] [Related]

  • 17. A role for renin in rebound hypertension and encephalopathy after infusion of saralasin acetate (Sar1-Ala8-angiotensin II).
    Keim HJ, Drayer JI, Case DB, Lopez-Ovejero J, Wallace JM, Weber MA, Laragh JH.
    N Engl J Med; 1976 Nov 18; 295(21):1175-7. PubMed ID: 980020
    [No Abstract] [Full Text] [Related]

  • 18. [Saralasin test, renal vein renin and unilateral kidney blood flow in renovascular hypertension].
    Helber A, Hummerich W, Bönner G, Meurer KA, Moritz G.
    Verh Dtsch Ges Kreislaufforsch; 1977 Nov 18; 43():208-9. PubMed ID: 613575
    [No Abstract] [Full Text] [Related]

  • 19. Use of an angiotensin II antagonist (saralasin) in the recognition of "angiotensinogenic" hypertension;
    Streeten DH, Anderson GH, Freiberg JM, Dalakos TG.
    N Engl J Med; 1975 Mar 27; 292(13):657-62. PubMed ID: 235090
    [Abstract] [Full Text] [Related]

  • 20. [Significance of the saralasin infusion test in the diagnosis of arterial hypertension].
    Glorioso N, Madeddu P, Dessì-Fulgheri P, Meloni F, Palermo M, Fiori C, Rappelli A.
    Boll Soc Ital Cardiol; 1980 Mar 27; 25(9):1035-46. PubMed ID: 7025868
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.